Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:e42
doi: 10.1161/01.CIR.0000028402.47626.62
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pontiroli, A. E.
Right arrow Articles by McMahon, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pontiroli, A. E.
Right arrow Articles by McMahon, A. D.
Related Collections
Right arrow Obesity
Right arrow Risk Factors
Right arrow Electrocardiology
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Chronic ischemic heart disease

(Circulation. 2002;106:e42.)
© 2002 American Heart Association, Inc.


Correspondence

Plasma Leptin Levels and Coronary Heart Disease

Antonio E. Pontiroli, MD; Pierluigi Pizzocri, MD; Franco Folli, MD

Università degli Studi di Milano, Cattedra di Medicina Interna, Ospedale San Paolo, Divisione di Medicina 2°, Ospedale San Raffaele, Divisione di Medicina, Milano, Italy

To the Editor:

In the West of Scotland Coronary Prevention (WOSCOP) study, Wallace et al1 show that plasma leptin levels predict coronary heart disease (CHD), and they interpret this finding on the basis of the known relationships between leptin and several facets of the metabolic syndrome, including high body mass index (BMI), insulin resistance, arterial hypertension, and of the relationship between leptin and C-reactive protein, a marker of inflammation and a predictor of CHD events.1 Other interpretations are possible. We analyzed BMI, serum leptin levels, and the QT interval (QTc) in 45 morbidly obese subjects, and we found that loss of weight obtained through laparoscopic adjustable gastric banding (from 44.6±1.01 kg/m2 to 35.6±0.89 kg/m2 in one year) is accompanied by a significant decrease of leptin levels (from 36.9±2.94 ng/mL to 19.7±2.04 ng/mL) and of the QTc (from 407.7±3.69 ms to 391.9±3.57 ms). Considering basal values, as well as values registered under basal conditions and after one year, we found significant relationships between BMI and leptin (r=0.63, P<0.001; r=0.72, P<0.001, respectively), and between leptin and QTc (r=0.57, P<0.001; r=0.52, P<0.001, respectively).

A long QTc, frequent in obese and in hypertensive subjects, is a risk factor for ventricular arrhythmia and sudden death2; in addition, leptin levels correlate with heart rate in healthy individuals,3 in heart-transplant recipients, 4 and with blood pressure. 1 Indeed, in the WOSCOP study, subjects with CHD events had higher systolic and diastolic blood pressure than subjects without events1; however, no data were given for their heart rate, nor whether cases were fatal or nonfatal. Leptin acts in the central nervous system, via interaction with several neuromediators in the hypothalamus, and may represent a partial link between excess weight gain and increased sympathetic activity5; in turn, increased sympathetic activity can lead to increased heart rate and long QTc. In summary, it is tempting to speculate that leptin can be involved in increased heart rate and in long QTc, thus amplifying the risk for CHD and sudden death.

References

1. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation. 2001; 104: 3052–3056.[Abstract/Free Full Text]

2. Frank S, Colliver JA, Frank A. The electrocardiogram in obesity: statistical analysis of 1029 patients. J Am Coll Cardiol. 1986; 7: 295–299.[Abstract]

3. Narkiewicz K, Kato M, Phillips BG, et al. Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens. 2001; 19: 1089–1094.[CrossRef][Medline] [Order article via Infotrieve]

4. Winnicki M, Phillips BG, Accurso V, et al. Independent association between plasma leptin levels and heart rate in heart transplant recipients. Circulation. 2001; 104: 384–386.[Abstract/Free Full Text]

5. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001; 14: 103–115.


 

Response

Naveed Sattar, MD, PhD; Peter W. Macfarlane, PhD; Chris J. Packard, DSc; Anne Kelly, MIBiol; James Shepherd, PhD; Allan Gaw, MD; A. Michael Wallace, PhD

Departments of Pathological Biochemistry, Cardiology, Clinical Trials Unit Glasgow Royal Infirmary, Glasgow, Scotland, UK

Alex D. McMahon, PhD

Robertson Center for Biostatistics, University of Glasgow, Glasgow, Scotland, UK

We thank Pontiroli and colleagues for their interesting comments in relation to our paper1 on leptin as a novel risk factor for coronary heart disease (CHD). We accept that mechanisms other than those proposed in our article, including increased heart rate and long QTc, may link leptin to CHD. Fortunately, such parameters were measured at baseline in the West of Scotland Coronary Prevention Study (WOSCOPS) and we have therefore examined the relationship between leptin and the above parameters. In the 783 control subjects with leptin measurements, log leptin did not correlate with heart rate (r=0.03, P=0.39) but did so positively with QTc (r=0.10, P=0.005). However, body mass index (BMI) also correlated with QTc (r=0.15, P<0.001) and the association of leptin with QTc was lost with adjustment for BMI (r=0.018, P=0.62). This observation contrasts with findings for established risk factors such as C-reactive protein and triglyceride that do correlate with leptin independently of BMI. These data suggest that total adiposity rather than fat mass per se is linked to increased QTc.

References

1. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation. 2001; 104: 3052–3056.[Abstract/Free Full Text]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pontiroli, A. E.
Right arrow Articles by McMahon, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pontiroli, A. E.
Right arrow Articles by McMahon, A. D.
Related Collections
Right arrow Obesity
Right arrow Risk Factors
Right arrow Electrocardiology
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Chronic ischemic heart disease